# COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment

> **NCT04743232** · NA · SUSPENDED · sponsor: **Erasmus Medical Center** · enrollment: 200 (actual)

## Conditions studied

- Covid19
- Cardiac Arrest

## Interventions

- **OTHER:** Decision tool for clinicians

## Key facts

- **NCT ID:** NCT04743232
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** Because the COVID pandemic became less severe (omikron)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04743232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04743232, "COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04743232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*